This document provides guidance on the evaluation of medicinal products for the prevention of nausea and vomiting associated with cancer chemotherapy.
Keywords: Chemotherapy, nausea, vomiting
Current effective version
Guideline on non-clinical and clinical development of medicinal products for the treatment of nausea and vomiting associated with cancer chemotherapy
English (EN) (112.3 KB - PDF)
Document history
Guideline on non-clinical and clinical development of medicinal products for the treatment of nausea and vomiting associated with cancer chemotherapy
English (EN) (112.3 KB - PDF)
Overview of comments on draft guideline on non-clinical and clinical development of medicinal products for the treatment of nausea and vomiting associated with cancer chemotherapy
English (EN) (127.49 KB - PDF)
Draft guideline on non-clinical and clinical development of medicinal products for the treatment of nausea and vomiting associated with cancer chemotherapy
English (EN) (83.38 KB - PDF)
Related content
- Clinical efficacy and safety: alimentary tract and metabolism
- Directive 2001/83/EC
- Choice of a non-inferiority margin
- Multiplicity issues in clinical trials
- ICH E7 Studies in support of special populations: geriatrics
- ICH E9 Statistical principles for clinical trials
- ICH E10 Choice of control group in clinical trials
- ICH M3 (R2) Non-clinical safety studies for the conduct of human clinical trials for pharmaceuticals